Cameroon’s Drug-Resistant Tuberculosis Patients Fall Short of National Cure Targets, Major Review Finds
A new systematic review of fifteen studies finds that only 74.2 percent of drug-resistant tuberculosis patients in Cameroon achieve treatment ...
A new systematic review of fifteen studies finds that only 74.2 percent of drug-resistant tuberculosis patients in Cameroon achieve treatment ...
A two-stage analysis combining FDA adverse event reports with Japanese claims data found aripiprazole associated with a significantly lower risk ...
An analysis of nearly half a million clinical trials and real-world data from over 91,000 patients reveals that immune-related side ...
A 608-patient multicenter study in China found that delamanid-containing regimens for multidrug-resistant tuberculosis showed a safety profile consistent with clinical ...
A large retrospective cohort study of 505 meta-analyses finds that most early evidence on medication harms expires within about three ...
A Danish study of 589 mother–child pairs links azole antifungal use in pregnancy to altered adrenal hormone levels in infants, ...
A George Mason statistician has received FDA funding to develop regulatory-grade frameworks that quantify how record linkage errors affect the ...
A new genetics-based framework systematically flags potential safety risks for inflammatory bowel disease drug targets before broad clinical exposure.
A 15-year analysis of 454 herbal medicine adverse event reports at a Korean integrative medical center shows that nearly a ...
An analysis of six years of FDA adverse event reports finds disproportionately high reporting odds of hair loss among patients ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine